Integra LifeSciences Names Ken Yamada Director of Sales for Asia
PLAINSBORO, N.J., Dec. 3, 2009 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the appointment of Ken Yamada as Director of Sales, Asia for Integra LifeSciences, effective immediately.
Mr. Yamada has a wealth of senior sales and marketing experience in the medical device industry, with a specific focus on business development in the Asian markets. He is fluent in Japanese and has worked in and out of Asia for over 15 years. As Director of Sales, Asia, Mr. Yamada will provide strategic direction and leadership, and invest in both the sales and regulatory infrastructure in order to grow Integra's business in all of Asia.
"We are delighted that Ken is joining our Integra team," said Debbie Leonetti, President of Integra Surgical. "His depth of experience will help us expand our business throughout Asia. Ken also has an extensive knowledge of both the local and global competitors within the Asian markets, which will help Integra position its products and grow the business."
Mr. Yamada joins Integra following six years as Managing Director and Senior Consultant, Pacific Rim and Middle East, at MedicalWrx Consultants, where he worked with many neurosurgical, orthopedic and spine clients to support market rollout and regulatory strategies. He was also instrumental in identifying sales and marketing distribution partners in Asia and the Middle East. Prior to his tenure with MedicalWrx Consultants, Mr. Yamada held positions at Ortho Development Corporation and Japan MDM.
"I am very pleased to join Integra," said Ken Yamada. "The company is well positioned to grow its business in the Asian markets and I'm looking forward to being a part of such a dynamic, global medical device company."
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients each year. The company's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
IART - G
CONTACT: Integra LifeSciences Holdings Corporation
Gianna Sabella
Director of Corporate Communications
(609) 936-2389
gsabella@integra-LS.com
(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.